A leader in research, Stony Brook's Division of Pediatric Infectious Diseases oversees a continuously growing roster of clinical trials. National pediatric clinical trials conducted on site have included novel vaccines targeting RSV, Streptococcus pneumoniae, parainfluenza 3, Lyme disease, and influenza. The Division has also conducted studies of new antibiotics and antivirals.
Faculty members within the Division of Pediatric Infectious Diseases have been published extensively in prominent medical journals, including the New England Journal of Medicine, Lancet, Journal of the American Medical Association (JAMA), Pediatrics, and the Journal of the Pediatric Infectious Diseases Society (JPIDS).
Current research focuses include:
- COVID-19 therapeutics
- National and regional COVID-19 pediatric database contributions
- Antibiotic-resistant bacteria
- Antibiotic stewardship interventions for primary care physicians
- Long-acting injectable HIV treatments
- Shortened treatment regimens for latent tuberculosis infections (LTBI)
- Pneumococcal, RSV, and other vaccine trials
- Local Chagas disease epidemiology
- Novel Lyme disease diagnostics
Our faculty are also serve on statewide and national infectious disease organizations, including:
- Chair of the International Maternal, Pediatric, Adolescent AIDS Clinical Trials (IMPAACT) Network
- Member, Fellowship Program Directors Committee, Pediatric Infectious Diseases Society (PIDS)
- Social Media Editor, Journal of the Pediatric Infectious Diseases Society (JPIDS)
- PIDS Publications Committee
- New York State DOH Antimicrobial Resistance Task Force
- Solutions for Patient Safety – National Advisory Committee for Antimicrobial Stewardship Programs
- Previous advocacy presentations to the New York State Legislature and United States Congress
For children growing up with HIV, access to clinical research can make a tremendous difference in their quality of life and prognosis. As the Designated AIDS Center (DAC) for Suffolk County, Stony Brook has been intricately involved in studying new therapies and new combinations of therapies to treat HIV, since 1985. The Division of Pediatric Infectious Diseases is devoted to the pursuit of new and better ways to prevent, diagnose and treat HIV-infected children, offering 15 to 20 clinical studies of new medications and therapies at any given time. Studies include trials sponsored by National Institutes of Health (NIH) as well as industry-funded studies. Stony Brook has been a PACTG/IMPAACT funded site since 1992 and is currently offering participation in 11 HIV/AIDS clinical trials, including three that assess H1N1 flu vaccines in HIV-infected women and children.